OpenVSafe by OpenVAERS
Search V-safe

A9P-19062-32616

2 vaccinations 2 coded responses 16 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
443 / OH
Registered
2021-01-16
Relationship
Self
Race
White
Ethnicity
N/A

Timeline

  1. 2021-01-16
    Registered in v-safe
  2. 2021-01-16
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-16
    Health check-in — day 0, dose 1
    Feeling: Good · Fatigue or tiredness, Nausea
    Adult check-in
  4. 2021-01-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-01-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Nausea
    Adult check-in
  7. 2021-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-23
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-30
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-06
    Dose 2 — Pfizer-BioNTech
  11. 2021-02-13
    Health check-in — day 7, dose 2
    Feeling: Good · Site: Pain, Redness, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work
    Adult check-in
  12. 2021-02-20
    Survey response — day 14, dose 2
    MedDRA: Fatigue — Feeling: Fair
    Free text: Fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-02-27
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-03-06
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-03-13
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-03-20
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-05-08
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-08-09
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2022-02-08
    Survey response — 12 months, dose 2
    MedDRA: Emergency care, Muscular weakness, Neurological symptom, Tremor — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Transient stroke-like symptoms (ED visit), muscle weakness and tremors that are not attributed to any underlying condition, despite evaluation of many possible conditions.
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-02-08
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  21. 2022-02-09

Vaccinations

DoseDateManufacturerCo-administered
12021-01-16Pfizer-BioNTech
22021-02-06Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 4 — day 14, dose 2

2021-02-20

Symptoms: Fatigue

Release 11 — 12 months, dose 2

2022-02-08

Symptoms: Transient stroke-like symptoms (ED visit), muscle weakness and tremors that are not attributed to any underlying condition, despite evaluation of many possible conditions.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDEmergency care · · ✓
SDFatigue ✓ ✓ ✓
SDMuscular weakness · · ✓
SDNeurological symptom · · ✓
SDTremor · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release